Copyright
©The Author(s) 2016.
World J Gastroenterol. Aug 14, 2016; 22(30): 6817-6828
Published online Aug 14, 2016. doi: 10.3748/wjg.v22.i30.6817
Published online Aug 14, 2016. doi: 10.3748/wjg.v22.i30.6817
Characteristic | Type I G-NETs | Type II G-NETs | Type III G-NETs |
Proportion of all G-NETs | 70%-80% | 5%-10% | 10%-15% |
Associated disease | Chronic atrophic gastritis | MEN type 1/ZES | None |
Gender | Women > men | Women = men | Women < men |
Tumor number | multiple | multiple | single |
Tumor size | < 10 mm | < 10 mm | > 10 mm |
Tumor location | fundus or corpus | fundus or corpus | Any region |
Histology | Usually NET G1 | NET G1/G2 | Usually NEC G3 |
Invasion depth | Mucosa or submucosa | Mucosa or submucosa | Any depth |
Serum gastrin | High | High | Normal |
Gastric pH | High | Low | Normal |
Risk of Metastasis | 2%-5% | 10%-20% | > 50% |
Prognosis | Excellent | Good | Poor |
- Citation: Sato Y, Hashimoto S, Mizuno KI, Takeuchi M, Terai S. Management of gastric and duodenal neuroendocrine tumors. World J Gastroenterol 2016; 22(30): 6817-6828
- URL: https://www.wjgnet.com/1007-9327/full/v22/i30/6817.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i30.6817